The COVID-19 pandemic has prompted extensive disruptions to the daily lives of children and adolescents worldwide, which has been associated with an increase in anxiety and depressive symptoms in youth. However, due to public health measures, in-person psychosocial care was initially reduced, causing barriers to mental health care access. This study investigated the feasibility, acceptability and preliminary effectiveness of iCOPE with COVID-19, a brief telemental health intervention for children and adolescents to address anxiety symptoms. Sessions were provided exclusively using videoconferencing technology. Feasibility and acceptability were measured with client satisfaction data. The main outcome measure for effectiveness was anxiety symptom severity measured using the Screen for Child Anxiety and Related Disorders (SCARED). Results indicated that the treatment was well accepted by participants. Significant reductions in anxiety were noted for social anxiety, and were observed to be trending towards a mean decrease for total anxiety. The findings suggest that this brief telemental health intervention focused on reducing anxiety related to COVID-19 is acceptable and feasible to children and adolescents. Future research using a large sample and with a longer follow-up period could inform whether symptom decreases are sustained over time.

COVID-19 大流行已对全世界儿童和青少年的日常生活造成广泛破坏，这与青少年焦虑和抑郁症状的增加有关。然而，由于公共卫生措施，最初减少了面对面的心理社会护理，从而导致获得精神卫生保健的障碍。本研究调查了 iCOPE 与 COVID-19 的可行性、可接受性和初步有效性，这是一种针对儿童和青少年的简短远程心理健康干预，以解决焦虑症状。会议专门使用视频会议技术提供。可行性和可接受性是用客户满意度数据来衡量的。有效性的主要结果测量是使用儿童焦虑和相关疾病筛查 (SCARED) 测量的焦虑症状严重程度。结果表明，参与者很好地接受了治疗。注意到社交焦虑的焦虑显着减少，并且观察到总体焦虑趋向于平均减少。研究结果表明，这种旨在减少与 COVID-19 相关的焦虑的简短远程心理健康干预对儿童和青少年来说是可以接受和可行的。未来的研究使用大样本和更长的随访期可以了解症状减轻是否会随着时间的推移而持续。研究结果表明，这种旨在减少与 COVID-19 相关的焦虑的简短远程心理健康干预对儿童和青少年来说是可以接受和可行的。未来的研究使用大样本和更长的随访期可以了解症状减轻是否会随着时间的推移而持续。研究结果表明，这种旨在减少与 COVID-19 相关的焦虑的简短远程心理健康干预对儿童和青少年来说是可以接受和可行的。未来的研究使用大样本和更长的随访期可以了解症状减轻是否会随着时间的推移而持续。